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 Abstract 
 Background: ROTEM  ®  is considered a helpful point-of-care 
device to monitor blood coagulation in emergency situations. 
Centrally performed analysis is desirable but rapid transport 
of blood samples is an important prerequisite. The effect of 
acceleration forces on sample transport through a pneumatic 
tube system on ROTEM  ®  should be tested at each institution 
to exclude a pre-analytical infl uence. The aims of the pres-
ent work were: (i) to investigate the effect of pneumatic tube 
transport on ROTEM  ®  parameters; (ii) to compare blood 
sample transport via pneumatic tube vs. manual transporta-
tion; and (iii) to determine the effect of acceleration forces on 
ROTEM  ®  parameters. 
 Methods: This is a single centre study with 20 healthy volun-
teers. Five whole blood samples were transferred to the central 
haematology laboratory by either normal transport or pneumatic 
delivery with different speed and acceleration forces. EXTEM, 
INTEM, FIBTEM and APTEM were analysed in parallel with 
two ROTEM  ®  devices and compared. Acceleration forces were 
measured during transport with two different instruments. 
 Results: Increment of transport time, speed and distance 
resulted in an augmentation of acceleration forces and peaks. 
All results of the ROTEM  ®  analysis after manual transport 
or pneumatic delivery were within normal range. However, 
increase in acceleration forces resulted in minimally but sta-
tistically signifi cant changes in multiple ROTEM  ®  parame-
ters. The higher the acceleration forces, the more ROTEM  ®  
parameters are infl uenced. 
 Conclusions: Acceleration forces during transport through 
a pneumatic tube system have an infl uence on ROTEM  ®  
parameters. Prior to transfer blood samples via pneumatic 
tube system these infl uences should be tested to exclude 
clinically relevant blood coagulation activation in vitro. 
 Keywords:  acceleration forces;  coagulation;  laboratory based 
ROTEM ® ;  pneumatic tube transport;  point-of-care. 
 Introduction 
 The modifi ed rotation thrombelastometry (ROTEM  ®  ) was 
developed as a point-of-care coagulation monitoring device. 
The automatised system allows determination of the coagu-
lation proprieties of whole blood during clot formation and 
lysis  (1) . With simple handling the method enables rapid anal-
ysis and results are graphically visualised live on a display. 
The device shows four pictures named EXTEM, INTEM, 
FIBTEM and APTEM which depict the clotting process after 
activation with different agonist. The coagulation is activated 
either with ellagic acid, which leads to a standardised acti-
vation of the contact phase of the intrinsic system (INTEM) 
or thromboplastin from rabbit brain which is used for the 
activation of the extrinsic coagulation system (EXTEM). In 
addition, reagents, such as aprotinin (APTEM) or cytochala-
sin D (FIBTEM) are used in order to study the EXTEM with 
(in vitro) inhibition of fi brinolytic activity (APTEM) and the 
EXTEM with inhibition of platelets (FIBTEM), respectively. 
Results are available 10 – 15 min after blood collection. The 
device is fast and is helpful especially in emergency situa-
tions with life-threatening bleeding  (2) . The four pictures 
should enable the coagulation defect to be identifi ed and a 
therapeutic option to be found. During emergency treatment, 
the simultaneous execution of ROTEM  ®  analysis represents 
an additional task for the attending team. The ROTEM  ®  delta 
device allows real time transmission of on-going ROTEM  ®  
results to different sites without time delay. This option 
encourages installing and performing ROTEM  ®  analysis in 
a central laboratory. Consequently, rapid transport of blood 
samples to a central laboratory is a prerequisite. Automated 
transport systems have been developed to reduce the turn-
around time and workload. Pneumatic tube systems are 
widely used in hospitals  (3) . Transport of blood samples 
through the pneumatic tube system may be advantageous also 
for ROTEM  ®  analysis. However, samples in the pneumatic 
tube are subjected to acceleration and deceleration forces nec-
essary to achieve high speed in order to cover long distances 
quickly. Pneumatic tube systems vary in diameter, size of the 
capsule, number of lines and transfer stations as well as forces 
to achieve the necessary speed. These forces on blood sam-
ples are known to cause certain cell damage infl uencing rou-
tine haematology results  (4, 5) . Signifi cant changes in lactate 
dehydrogenase concentrations  (6) , effects on blood gas mea-
surements  (7 – 9) and on thromboelastographic analysis with 
the TEG 5000  ®   (4) have been described. Pre-analytical effects 
of pneumatic tube transport on coagulation parameters and 
 *Corresponding author: Giuseppe Colucci, Department of 
Haematology and Central Haematology Laboratory Inselspital, 
Bern University Hospital and University of Bern, Freiburgstrasse 
10, 3010 Bern, Switzerland 
Phone:  + 41 31 6320264, Fax:  + 41 31 6323406 , 
E-mail:  giuseppe.colucci@insel.ch 
 Received October 31, 2011; accepted February 6, 2012; 
previously published online March 9, 2012 
1336  Amann et al.: Effect of acceleration forces on ROTEM ® 
platelet function have also been evaluated  (10 – 12) . Finally, 
each pneumatic transport system possesses a unique technical 
and structural pattern and should be tested for pre-analytical 
effects  (13) , including effects with regard to ROTEM  ®  analy-
sis  (14) . Indeed the manufacturer of the ROTEM  ®  delta device 
advises against the transport of blood samples via pneumatic 
tube unless the infl uence of local mechanical transport system 
is investigated. 
 The aims of the present work were: (i) to investigate the 
effect of pneumatic tube transport on ROTEM  ®  parameters; 
(ii) to compare blood sample transport via pneumatic tube vs. 
manual transport; and (iii) to determine the effect of accelera-
tion forces on ROTEM  ®  parameters. 
 Materials and methods 
 The study was performed at the Kantonsspital Winterthur after ap-
proval from the Local Ethics Committee (Kantonale Ethikkommission 
Z ü rich, KEK-ZH-Nr. 2011-0222). After informed consent, 20 healthy 
volunteers were recruited and prospectively enrolled by medical 
personal at our institution. Exclusion criteria were: (i) age under 18 
years; (ii) systolic blood pressure below 100 mm Hg; (iii) known 
coagulation disorders; (iv) illness or surgery in the last 4 weeks; (v) 
transfusion in the last 12 months; and (vi) intake of any medica-
tion including contraceptives and analgesics. Whole blood samples 
were collected from an anticubital vein into fi ve 4.3 mL plastic vials 
(S-Monovette  ®  4.3 mL 0NC; Sarstedt, N ü mbrecht, Germany) con-
taining 0.43 mL 0.106 mol/L trisodium citrate solution. All samples 
were collected in the central operating unit and labelled A, B, C, D 
and E, respectively. Sample A was delivered manually to the central 
haematology laboratory at room temperature. Sample B was sent by 
pneumatic tube system with a velocity of 3 m/s according to local 
standard  “ priority ” mode. Samples C, D and E were sent through the 
pneumatic tube system with a velocity of 7 m/s for 270 m, 540 m and 
1080 m, respectively (Table  1 ).  
 Pneumatic tube system and acceleration forces 
 The pneumatic tube system at the Kantonsspital Winterthur 
(Transmatic MC 14/NW 125; Transro AG, Wohlen, Switzerland) is a 
one-tube-system consisting of 14 lines with intersection at two trans-
fer stations. Blood samples sent to the central laboratory have a stan-
dard  “ priority ” mode (direct transfer) and a velocity of 3 m/s. The 
capsules sent to destinations outside the central laboratory have a ve-
locity of 7 m/s. To measure the acceleration forces during pneumatic 
delivery, we used two devices: IPod touch (Apple  ®  Inc.; Cupertino, 
USA) with an associated application (SensorData, Wavefront Labs  ©  ; 
distributed by Apple  ®  Inc.; Cupertino, USA) which measures linear 
and rotation acceleration forces with a frequency of 100 Hz (see 
Supplemental data Figure  1A ; accompanies the online version 
of this article at http://www.degruyter.com/view/j/cclm.2012.50.
issue-8/issue-fi les/cclm.2012.50.issue-8.xml). This device was fi xed 
to the capsule (see Supplemental data Figure  2A ). Because the linear 
accelerations measured using the IPod are limited to maximal 2  g 
(unit of measure of acceleration due to gravity at the earth ’ s surface) 
we used a second device. The second device was a self recording im-
pact accelerometer X250-2 (Gulf Coast Data Concepts  © ; Waveland, 
USA) which measures with a frequency of 256 Hz. The latter is very 
light (33 g, see Supplemental data Figure 1B) and was placed inside 
the capsule close to the blood sample (see Supplemental data Figure 
2B). X250-2 measures forces in the range of  ± 28  g . The two devices 
measured accelerations in three axes x, y, z, and the raw data have to 
be corrected for an offset value (for details see Supplemental data). 
Acceleration forces are expressed as area under the curve (AUC) and 
numbers of acceleration peaks (n). 
 ROTEM  ®  analysis 
 Analysis of all samples was performed using two identical ROTEM  ®  
delta devices (ROTEM  ®  1 and ROTEM  ®  2; Axon Lab AG, Baden, 
Switzerland) placed at the central haematology laboratory of the 
Kantonsspital Winterthur. Quality control of the devices was per-
formed initially following the internal quality protocol with the respec-
tive reagent (ROTROL N; Pentapharm AG Basel, Switzerland). All 
tests were performed by the fi rst author of this study, who was initially 
trained and supervised by qualifi ed laboratory staff. Prior to ROTEM  ®  
analysis, all samples were placed over the ROTEM  ®  delta devices at 
37 ° C for 5 min and all measurements were performed at this tempera-
ture. The reagents, stored at temperatures between 4 ° C and 8 ° C, were 
kept at room temperature for 10 min and shaken gently before pipetted. 
INTEM, EXTEM, FIBTEM and APTEM test were performed as de-
scribed previously  (14) . For each analysis standard ROTEM  ®  param-
eters, such as clotting time (CT, s), A5 (clot thickness after 5 min, 
mm), A10 (clot thickness after 10 min, mm), A15 (clot thickness after 
15 min, mm), A30 (clot thickness after 30 min, mm), clot formation 
time (CFT, s), maximum clot fi rmness (MCF, mm), alpha ( α , angle) 
LI30 (lysis index after 30 min), LI45 (lysis index after 45 min), ML 
(maximal lysis) and AUC (area under the curve) were measured. These 
parameters describe: (i) the period from analysis start until a 2 mm 
amplitude occurs (CT); (ii) the subsequent period until an amplitude of 
20 mm is reached (CFT); (iii) the kinetics of clot formation ( α ); (iv) 
the clot fi rmness at different time points (A5 after 5 min, A10 after 10 
min, A15 after 15 min and A30 after 30 min); (v) the maximum fi rm-
ness that the clot achieves during the analysis (MCF); (vi) the fi brin-
olysis at particular time point (LI30 after 30 min, LI45 after 45 min); 
and (vii) the maximum fi brinolysis detected (ML). 
 Statistical analysis 
 All quantitative data are expressed as median and interquartile 
range (IQR). Non-parametric statistic was applied and performed 
with SPSS Statistics Version 19  ©  software (SPSS Inc., Chicago, 
 Table 1  Study design (results expressed as median and interquartile range, IQR). 
Delivery mode Total distance Speed Pneumatic 
transport time
Linear acceleration 
forces (AUC)
Linear acceleration 
peaks  > 25 g (n)
Sample A Manual   50 m Walk  –  –  – 
Sample B Pneumatic priority 270 m 3 m/s 135 s (117 – 149) 95.9 (93.3 – 99.3)   3.5 (3 – 4)
Sample C Pneumatic normal 270 m 7 m/s 176 s (152 – 203) 116.3 (114.5 – 117.7)   4.5 (4 – 8)
Sample D Pneumatic normal 540 m 7 m/s 334 s (315 – 390) 213.1 (208.2 – 223.3)   9.0 (5 – 10)
Sample E Pneumatic normal 1080 m 7 m/s 652 s (568 – 852) 413.2 (406.5 – 427.3) 18.5 (13 – 22)
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IL, USA), SigmaPlot 11.0 (Systat Software, Inc., Chicago, USA) 
and Microsoft Excel 2010  ©  (Microsoft Corporation; Redmont, OR, 
USA). Comparisons were performed with the Wilcoxon signed rank 
test. A two-tailed p value of  < 0.05 was considered signifi cant. The 
offset correction of the X250-2 logger, the AUC of the accelera-
tion vectors and the peaks were calculated with Octave 3.2.4 (Free 
Software Foundation; Boston, MA, USA). 
 Results 
 Twenty healthy volunteers [median age 41.4 years (range 
27 – 52), comprising 8 women [median age 47 years (range 28 –
 52)] and 12 men [median age 34 years (range 27 – 49)]] were 
enrolled. All citrated blood samples were labelled A, B, C, D, 
E, respectively and sent through pneumatic delivery system 
with a defi ned velocity (samples B – E) or hand carried to cen-
tral laboratory (sample A, Table 1). Median transport time of 
sample A was 157 seconds (s) (IQR: 147 – 169 s). Median trans-
port time in the pneumatic tube was 135 s (IQR: 117 – 149 s) 
for sample B, 176 s (IQR: 152 – 203 s) for sample C, 334 s (IQR: 
315 – 390 s) for sample D, 652 s (IQR: 568 – 852 s) for sample 
E, respectively. The rotation acceleration force measured with 
IPod (median AUC, rad/s) was 3745 (IQR: 3674 – 3833, range 
4.24 % ) for sample B, 4400 (IQR: 4342 – 4460, range 2.67 % ) 
for sample C, 8557 (IQR: 8526 – 8602, range 0.88 % ) for 
sample D and 17249 (IQR: 17101 – 17353, range 1.47 % ) for 
sample E, respectively. The linear acceleration forces (median 
AUC, m/s) measured with the device placed inside the capsule 
(X250-2) was 95.9 (IQR: 93.9 – 99.3, range 5.59 % ) for sample 
B, 116.3 (IQR: 114.5 – 117.7, range 2.74 % ) for sample C, 213.1 
(IQR: 208.1 – 223.3, range 7.13 % ) for sample D and 413.2 
(IQR: 406.5 – 427.3, range 5.03 % ) for sample E, respectively. 
Linear acceleration peaks are summarised in Tables 1 and  2 . 
Median time between blood collection and start of ROTEM  ®  
test was 11 min (IQR: 10 – 12 min) for sample A, 17 min (IQR: 
16 – 20 min) for sample B, 81 min (IQR: 79 – 86 min) for sam-
ple C, 130 min (IQR: 126 – 144 min) for sample D and 157 min 
(IQR: 151 – 160 min) for sample E, respectively. 
 Table 2  Linear acceleration peaks measured during tube transport delivery (n, median and IQR). 
Sample A Sample B Sample C Sample D Sample E
  > 1 g  – 7928 (7634 – 8119) 9791 (9319 – 10247) 18143 (17817 – 19822) 35676 (35138 – 37934)
  > 2 g  – 2445 (2331 – 2551) 3399 (3048 – 3581) 6118 (5689 – 6671) 11551 (11432 – 12462)
  > 4 g  – 598 (545 – 627) 835 (767 – 903) 1526 (1476 – 1599) 3027 (2833 – 3208)
  > 8 g  – 118 (95 – 132) 186 (158 – 216) 331 (232 – 431) 748 (545 – 806)
 > 16 g  – 19.0 (16 – 23) 31.5 (22 – 45) 51 (29 – 76) 126 (89 – 142)
 > 25 g  – 3.5 (3 – 4) 4.5 (4 – 8) 9.0 (5 – 10) 18.5 (13 – 22)
 Table 3  Results of thromboelastometry: manual transport (sample A) and pneumatic delivery (3 m/s, 270 m: sample B): median and 
interquartile range (IQR). 
EXTEM INTEM
Sample A (manual) Sample B p-Value Sample A (manual) Sample B p-Value
CT   50 (47 – 54)   51 (46 – 53)   0.738   176 (165 – 202)   169 (158 – 185)   0.245
A5   45 (41 – 48)   46 (42 – 48)   0.263   46 (43 – 49)   46 (43 – 49)   0.258
A10   56 (52 – 58)   56 (52 – 57)   0.021   55 (53 – 58)   55 (52 – 57)   0.182
A15   60 (57 – 62)   59 (56 – 60)  < 0.001   59 (56 – 62)   59 (56 – 60)   0.024
A30   62 (59 – 64)   61 (58 – 63)  < 0.001   60 (57 – 62)   58 (56 – 61)   0.004
CFT   86 (76 – 102)   87 (77 – 97)   0.734   66 (58 – 81)   66 (58 – 77)   0.869
MCF   62 (60 – 64)   61 (59 – 63)  < 0.001   62 (57 – 62)   60 (57 – 61)   0.027
 α   73 (70 – 74)   72 (71 – 75)   0.839   77 (74 – 78)   77 (75 – 78)   0.953
AUC 6212 (5933 – 6382) 6089 (5858 – 6249)  < 0.001 6118 (5678 – 6212) 5964 (5640 – 6087)   0.033
FIBTEM APTEM
Sample A (manual) Sample B p-Value Sample A (manual) Sample B p-Value
CT   46 (44 – 48)   47 (43 – 49)   0.922   51 (48 – 54)   48 (47 – 55)   0.756
A5   10 (10 – 13)   12 (10 – 13)   0.241   46 (40 – 49)   44 (43 – 48)   0.241
A10   11 (11 – 13)   12 (10 – 13)   0.277   55 (51 – 58)   55 (51 – 57)   0.135
A15   12 (11 – 14)   13 (10 – 13)   0.715   60 (57 – 62)   59 (55 – 61)   0.068
A30   12 (11 – 13)   13 (11 – 14)   0.561   62 (58 – 64)   61 (57 – 62)  < 0.001
CFT  –  –  –   88 (73 – 105)   89 (76 – 97)   0.277
MCF   12 (11 – 13)   13 (11 – 14)   0.706   62 (58 – 64)   61 (58 – 63)   0.021
 α   68 (63 – 72)   67 (64 – 70)   0.829   72 (69 – 75)   72 (71 – 74)   0.326
AUC 1183 (1112 – 1350) 1222 (1078 – 1335)   0.674 6209 (5818 – 6355) 6044 (5775 – 6248)   0.008
 ROTEM  ®  parameters: clotting time (CT, s), clot thickness (A5 after 5 min, A10 after 10 min, A15 after 15 min, A30 after 30 min, respectively, 
mm), clot formation time (CFT, s), maximum clot fi rmness (MCF, mm), alpha ( α , angle) and AUC (area under the curve). 
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 Table 4  Results of thromboelastometry: manual transport (sample A) and pneumatic delivery (7 m/s, 270 m: sample C): median and 
interquartile range (IQR). 
EXTEM INTEM
Sample A (manual) Sample C p-Value Sample A (manual) Sample C p-Value
CT   50 (47 – 54)   51 (48 – 53)   0.784   176 (165 – 202)   160 (152 – 182)   0.165
A5   45 (41 – 48)   44 (41 – 47)   0.001   46 (43 – 49)   45 (43 – 48)   0.089
A10   56 (52 – 58)   54 (51 – 57)  < 0.001   55 (53 – 58)   54 (52 – 57)   0.015
A15   60 (57 – 62)   57 (55 – 60)  < 0.001   59 (56 – 62)   57 (56 – 60)  < 0.001
A30   62 (59 – 64)   60 (57 – 62)  < 0.001   60 (57 – 62)   58 (56 – 60)  < 0.001
CFT   86 (76 – 102)   88 (73 – 98)   0.347   66 (58 – 81)   66 (58 – 74)   0.784
MCF   62 (60 – 64)   61 (58 – 62)  < 0.001   62 (57 – 62)   60 (57 – 61)  < 0.001
 α   73 (70 – 74)   72 (70 – 75)   0.893   77 (74 – 78)   77 (75 – 78)   0.632
AUC 6212 (5933 – 6382) 6024 (5743 – 6173)  < 0.001 6118 (5678 – 6212) 5890 (5638 – 6050)  < 0.001
FIBTEM APTEM
Sample A (manual) Sample C p-Value Sample A (manual) Sample C p-Value
CT   46 (44 – 48)   47 (44 – 48)   0.671   51 (48 – 54)   52 (48 – 55)   0.812
A5   10 (10 – 13)   11 (10 – 12)   1.000   46 (40 – 49)   43 (40 – 47)   0.004
A10   11 (11 – 13)   12 (10 – 13)   0.839   55 (51 – 58)   53 (50 – 56)  < 0.001
A15   12 (11 – 14)   12 (11 – 13)   0.520   60 (57 – 62)   57 (54 – 60)  < 0.001
A30   12 (11 – 13)   12 (11 – 13)   0.569   62 (58 – 64)   60 (56 – 62)  < 0.001
CFT  –  –  –   88 (73 – 105)   88 (73 – 99)   0.003
MCF   12 (11 – 13)   12 (11 – 13)   0.110   62 (58 – 64)   60 (57 – 62)  < 0.001
 α   68 (63 – 72)   69 (65 – 72)   0.252   72 (69 – 75)   72 (70 – 75)   0.013
AUC 1183 (1112 – 1350) 1158 (1081 – 1341)   0.349 6209 (5818 – 6355) 5984 (5679 – 6175)  < 0.001
 ROTEM  ®  parameters: clotting time (CT, s), clot thickness (A5 after 5 min, A10 after 10 min, A15 after 15 min, A30 after 30 min, respectively, 
mm), clot formation time (CFT, s), maximum clot fi rmness (MCF, mm), alpha ( α , angle) and AUC (area under the curve). 
 Table 5  Results of thromboelastometry: manual transport (sample A) and pneumatic delivery (7 m/s, 1080 m: sample E): median and 
interquartile range (IQR). 
EXTEM INTEM
Sample A (manual) Sample E p-Value Sample A (manual) Sample E p-Value
CT   50 (47 – 54)   48 (44 – 49)   0.008   176 (165.25 – 201.5)   156 (150 – 177)   0.058
A5   45 (41 – 48)   43 (40 – 46)  < 0.001   46 (43 – 49)   45 (41 – 48)   0.003
A10   56 (52 – 58)   53 (50 – 55)  < 0.001   55 (53 – 58)   54 (51 – 56)  < 0.001
A15   60 (57 – 62)   57 (55 – 60)  < 0.001   59 (56 – 62)   57 (54 – 59)  < 0.001
A30   62 (59 – 64)   60 (56 – 61)  < 0.001   60 (57 – 62)   58 (53 – 60)  < 0.001
CFT   86 (76 – 102)   91 (80 – 103)   0.442   66 (58 – 81)   72 (60 – 84)   0.202
MCF   62 (59 – 64)   60 (57 – 62)  < 0.001   62 (57 – 62)   59 (54 – 60)  < 0.001
 α   73 (70 – 75)   72 (69 – 74)   0.301   76 (74 – 78)   76 (74 – 78)   0.890
AUC 6212 (5933 – 6382) 5983 (5636 – 6159)  < 0.001 6118 (5678 – 6212) 5872 (5410 – 6015)  < 0.001
FIBTEM APTEM
Sample A (manual) Sample E p-Value Sample A (manual) Sample E p-Value
CT   46 (44 – 48)   44 (41 – 47)   0.001   51 (48 – 54)   49 (46 – 51)   0.096
A5   10 (10 – 13)   11 (10 – 12)   0.542   46 (40 – 49)   43 (39 – 46)  < 0.001
A10   11 (11 – 13)   11 (11 – 12)   0.080   55 (51 – 58)   52 (50 – 55)  < 0.001
A15   12 (11 – 14)   12 (11 – 13)   0.173   60 (57 – 62)   56 (54 – 59)  < 0.001
A30   12 (11 – 14)   13 (11 – 14)   0.678   62 (58 – 64)   59 (56 – 61)  < 0.001
CFT  –  –  –   88 (73 – 105)   91 (76 – 104)   0.490
MCF   12 (11 – 13)   12 (11 – 13)   0.263   62 (58 – 64)   60 (56 – 61)  < 0.001
 α   68 (63 – 72)   69 (64 – 72)   0.903   72 (69 – 75)   72 (69 – 75)   0.588
AUC 1183 (1112 – 1350) 1200 (1059 – 1298)   0.245 6209 (5818 – 6355) 5915 (5593 – 6104)  < 0.001
 ROTEM  ®  parameters: clotting time (CT, s), clot thickness (A5 after 5 min, A10 after 10 min, A15 after 15 min, A30 after 30 min, respectively, 
mm), clot formation time (CFT, s), maximum clot fi rmness (MCF, mm), alpha ( α , angle) and AUC (area under the curve). 
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 All results of the ROTEM  ®  analysis of sample A were within 
normal range (Table  3 )  (15) . Transport through the pneumatic 
tube system with a low velocity of 3 m/s (according to local 
standard  “ priority ” mode, sample B) produce minimal but sta-
tistically signifi cant changes in multiple parameters of EXTEM 
(A10, A15, A30, MCF and AUC, Table 3) and one parameter 
of INTEM and APTEM (A30, Table 3). Increase in accelera-
tion forces resulted in changes evident in multiple ROTEM  ®  
parameters (Tables 3 – 5 , and Supplemental data  Tables 1 and 2 ). 
The higher the acceleration forces, the more ROTEM  ®  param-
eters are infl uenced, including INTEM and APTEM (Tables 4 
and 5). FIBTEM is only minimally or not infl uenced by high 
acceleration forces (Table 5). Although these differences are 
statistically signifi cant, all results of ROTEM  ®  parameters of 
samples transported via pneumatic tube system are within the 
normal range. The changes in ROTEM  ®  parameters are more 
numerous with the increase in linear and rotation acceleration 
forces (Figures  1 – 3 , and Supplemental data Figure  3 ). Lysis 
parameters are infl uenced only by high acceleration forces (see 
Supplemental data Table  3 ). 
 Discussion 
 Originally designed as a point-of-care device, the ROTEM-
analyser allows a fast evaluation of coagulation function in 
whole blood. Results of ROTEM  ®  parameters are visualised 
live on display directly after the start of blood analysis. The 
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device may be useful, especially in emergency situations with 
severe bleeding where time is critical, the attending physi-
cian needs to obtain information on the type and dimension 
of a coagulation disorder fast. But often, emergency medical 
and nursing staff are busy treating the patient, and the perfor-
mance of laboratory analysis on site may be delayed. Under 
these circumstances it may be advantageous to perform 
analysis centrally. Rapid transportation of blood samples to 
the central laboratory is then a prerequisite. For this purpose 
pneumatic tube transport systems have been developed and 
are widely utilised today. To assure quality of analysis, blood 
coagulation activation by acceleration and deceleration along 
the trajectory in the pneumatic tube delivery system should be 
excluded. Comparison of manual and pneumatic delivery of 
blood samples should be performed to exclude pre-analytical 
infl uences  (13, 14) . The fi rst aim of the present study was to 
investigate the effect of transport on ROTEM  ®  parameters. 
We show that the mode of transport can infl uence the results. 
The second aim of this work was to compare blood sample 
transport via pneumatic tube vs. manual and we show that the 
differences, although minimal are signifi cant. At our institu-
tion, samples being sent to the central laboratory unit have a 
slow velocity (of 3 m/s) with a special, direct  “ priority-trans-
port ” . Our fi ndings show that although all results were within 
the normal ranges, the transport through the pneumatic system 
had infl uence on the multiple ROTEM  ®  parameters. Finally, 
to determine the effect of acceleration forces on ROTEM  ®  
results we used different speed and distances resulting in 
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augmentation of acceleration forces. To measure the accel-
eration forces we used two different accelerometers  (16) . We 
show that an increase in acceleration forces resulted in varia-
tion of multiple ROTEM  ®  parameters, especially amplitude 
(A) and maximum clot fi rmness (MCF). The changes in the 
ROTEM  ®  parameters are more numerous with the increase 
in linear and rotation acceleration forces. Interestingly, the 
FITBEM is infl uenced only minimally, even with high accel-
eration forces. The FIBTEM is like the EXTEM but presence 
of cytochalasin D blocks the contribution of platelets to whole 
blood coagulation. It is not excluded, that the result observed 
in this study could be caused by the alteration of thrombo-
cyte function. Of note, the FIBTEM is probably the ROTEM  ®  
parameter which mostly affects patients ’ management. 
 This study reinforces the thesis, that comparison of manual 
and local pneumatic delivery should be performed to exclude 
relevant in vitro blood coagulation activation  (14) . At each insti-
tution an evaluation of the transport system is necessary before 
samples are routinely transported with a pneumatic tube system. 
This evaluation is needed at each institution because the trans-
port systems are different (dependent on architectural, length 
differences, acceleration forces,  … ) and every single system 
should be considered as a unique entity. In the present work all 
results are within the normal range and differences are prob-
ably clinically not relevant. However, this conclusion cannot 
be extrapolated to patients with bleeding disorders. The com-
parison should be performed with patient samples as well. An 
additional weakness of this study is the time difference between 
1342  Amann et al.: Effect of acceleration forces on ROTEM ® 
blood collection, transportation and ROTEM  ®  analysis. This 
difference was due to the availability of only two ROTEM  ®  
devices. However, prior publications show stability of blood 
samples until 4 h after sampling  (15, 17) . In addition, our results 
show a difference already between manual and standard  “ pri-
ority ” mode and this difference slightly increases with accel-
eration and rotation forces. These results are discrepant but not 
contradictory to our previously published work  (14) because the 
studies are conducted at two different institutions with different 
tube transport systems and different acceleration forces. 
 In conclusion, acceleration forces during transport through 
a pneumatic tube system infl uence ROTEM  ®  parameters 
in whole blood samples in healthy volunteers. Prior to the 
transfer of blood samples via a pneumatic tube system these 
infl uences should be tested to exclude clinically relevant pre-
analytical blood activation in vitro. 
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